SERGLIFLOZIN ETABONATE
UNII 4HY3523466

Substance Identification & Data

This profile provides standardized clinical and technical data for Sergliflozin Etabonate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4HY3523466.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 408504-26-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

4HY3523466

CAS Registry Number

408504-26-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SERGLIFLOZIN ETABONATE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C23H28O9

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

QLXKHBNJTPICNF-QMCAAQAGSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C78129

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

9824918

Unique identification number in the NCBI database of chemical substances.

INN ID

8790

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

RR-47

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1ccc(c(O[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)COC(OCC)=O)c1)Cc3ccc(cc3)OC

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sergliflozin Etabonate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.